These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21076189)

  • 1. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation.
    Taddei PJ; Mahajan A; Mirkovic D; Zhang R; Giebeler A; Kornguth D; Harvey M; Woo S; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7067-80. PubMed ID: 21076189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.
    Taddei PJ; Mirkovic D; Fontenot JD; Giebeler A; Zheng Y; Kornguth D; Mohan R; Newhauser WD
    Phys Med Biol; 2009 Apr; 54(8):2259-75. PubMed ID: 19305045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of developing a second cancer after receiving craniospinal proton irradiation.
    Newhauser WD; Fontenot JD; Mahajan A; Kornguth D; Stovall M; Zheng Y; Taddei PJ; Mirkovic D; Mohan R; Cox JD; Woo S
    Phys Med Biol; 2009 Apr; 54(8):2277-91. PubMed ID: 19305036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
    Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
    Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation.
    Taddei PJ; Khater N; Zhang R; Geara FB; Mahajan A; Jalbout W; Pérez-Andújar A; Youssef B; Newhauser WD
    Cancers (Basel); 2015 Mar; 7(1):407-26. PubMed ID: 25763928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.
    Taddei PJ; Khater N; Youssef B; Howell RM; Jalbout W; Zhang R; Geara FB; Giebeler A; Mahajan A; Mirkovic D; Newhauser WD
    Biomed Phys Eng Express; 2018; 4(2):. PubMed ID: 30038799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.
    Athar BS; Paganetti H
    Phys Med Biol; 2009 Aug; 54(16):4907-26. PubMed ID: 19641238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent application of an analytical model for secondary neutron equivalent dose produced in a passive-scattering proton therapy treatment unit.
    Gallagher KJ; Taddei PJ
    Phys Med Biol; 2018 Aug; 63(15):15NT04. PubMed ID: 29978833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANALYTICAL MODEL TO ESTIMATE EQUIVALENT DOSE FROM INTERNAL NEUTRONS IN PROTON THERAPY OF CHILDREN WITH INTRACRANIAL TUMORS.
    Gallagher KJ; Taddei PJ
    Radiat Prot Dosimetry; 2019 Jun; 183(4):459-467. PubMed ID: 30272222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.
    Taddei PJ; Howell RM; Krishnan S; Scarboro SB; Mirkovic D; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7055-65. PubMed ID: 21076199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.
    Fontenot JD; Bloch C; Followill D; Titt U; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):6987-98. PubMed ID: 21076196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
    Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
    Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measured Neutron Spectra and Dose Equivalents From a Mevion Single-Room, Passively Scattered Proton System Used for Craniospinal Irradiation.
    Howell RM; Burgett EA; Isaacs D; Price Hedrick SG; Reilly MP; Rankine LJ; Grantham KK; Perkins S; Klein EE
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):249-257. PubMed ID: 27084645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.
    Fontenot JD; Lee AK; Newhauser WD
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):616-22. PubMed ID: 19427561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Monte Carlo-based analytic model of neutron dose equivalent for a mevion gantry-mounted passively scattered proton system for craniospinal irradiation.
    Baradaran-Ghahfarokhi M; Reynoso F; Sun B; Darafsheh A; Prusator MT; Mutic S; Zhao T
    Med Phys; 2020 Sep; 47(9):4509-4521. PubMed ID: 32473612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons.
    Gerweck LE; Huang P; Lu HM; Paganetti H; Zhou Y
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):161-6. PubMed ID: 24725699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.